Regulation of IFN-γ expression

Advances in Experimental Medicine and Biology

Volumn 941, Issue , 2016, Pages 1-19

  Fenimore, John ^a   Young, Howard A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Activator; Epigenetic control; IFN ; LncRNA; MicroRNA; Suppressor; Transcriptional control

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; CALSENILIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; EOMESODERMIN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 27; LONG UNTRANSLATED RNA; MICRORNA; STAT1 PROTEIN; STAT3 PROTEIN; STAT4 PROTEIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR T BET; TRANSCRIPTION FACTOR YY1; TRANSFORMING GROWTH FACTOR BETA;

CHROMATIN CONDENSATION; CHROMOSOME POSITIONING; CYTOKINE PRODUCTION; DNA METHYLATION; EPIGENETICS; GENE LOCUS; HISTONE ACETYLATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; TRANSCRIPTION REGULATION; ANIMAL; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PROMOTER REGION; PROTEIN PROCESSING; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

ANIMALS; GENE EXPRESSION REGULATION; HUMANS; INTERFERON-GAMMA; PROMOTER REGIONS, GENETIC; PROTEIN PROCESSING, POST-TRANSLATIONAL; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 84991669589     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-94-024-0921-5_1     Document Type: Chapter

References (86)

1. Wheelock EF. Interferon-like virus-inhibitor induced in human leukocytes by phytohemagglutinin. Science. 1965;149(3681):310-1.
2. Naylor SL, Sakaguchi AY, Shows TB, Law ML, Goeddel DV, Gray PW. Human immune interferon gene is located on chromosome 12. J Exp Med. 1983;157(3):1020-7.
3. Naylor SL, Gray PW, Lalley PA. Mouse immune interferon (IFN-γ) gene is on chromosome 10. Somat Cell Mol Genet. 1984;10(5):531-4.
4. Ushio S, Namba M, Okura T, Hattori K, Nukada Y, Akita K, Torigoe K, et al. Cloning of the cDNA for human IFN-gamma-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. J Immunol. 1996;156(11):4274-9.
5. Savan R, Ravichandran S, Collins JR, Sakai M, Young HA. Structural conservation of interferon gamma among vertebrates. Cytokine Growth Factor Rev. 2009;20(2):115-24.
6. Rusinova I, Forster S, Yu S, Kannan A, Masse M, Cumming H, Chapman R, Hertzog PJ. INTERFEROME v2. 0: an updated database of annotated interferon-regulated genes. Nucleic Acids Research. 2013 January; 41 (database issue): D1040-D1046. Smith NL, Dennings DW Clincal implications of interferon gamma genetic and epigenetic variants. Immunology 2014.
7. Kaufmann SH. Immunopathology of mycobacterial diseases. In Seminars in immunopathology (pp. 1-4). 2016. Berlin/Heidelberg: Springer.
8. Booty MG, Nunes-Alves C, Carpenter SM, Jayaraman P, Behar SM. Multiple inflammatory cytokines converge to regulate CD8+ T cell expansion and function during tuberculosis. J Immunol. 2016;169(4):1822-31.
9. Marciano BE, Wesley R, Ellen S, Anderson VL, Barnhart LA, Darnell D, Holland SM, et al. Long-term interferon-γ therapy for patients with chronic granulomatous disease. Clin Infect Dis. 2004;39(5):692-9.
10. Schoenborn JR, Wilson CB. Regulation of interferon-gamma during innate and adaptive immune responses. Adv Immunol. 2007;96:41-101.
11. Janeway CA, Travers P, Walport M, Shlomchik MJ. ImmunoBiology. 6th ed. New York: Garland Science Taylor and Francis Group; 2005.
12. Hirsch RL, Panitch HS, Johnson KP. Lymphocytes from multiple sclerosis patients produce elevated levels of gamma interferon in vitro. J Clin Immunol. 1985;5(6):386-9.
13. Sarvetnick N, Shizuru J, Liggitt D, Martin L, McIntyre B, Gregory A, et al. Loss of pancreatic islet tolerance induced by beta-cell expression of interferon-gamma. Nature. 1990;346:844-7.
14. Azar ST, Tamim H, Beyhum HN, Habbal MZ, Almawi WY. Type I (insulin-dependent) diabetes is a Th1-and Th2-mediated autoimmune disease. Clin Diagn Lab Immunol. 1999;6(3):306-10.
15. Collins PL, Chang S, Henderson M, Soutto M, Davis GM, McLoed AG, Aune TM, et al. Distal regions of the human IFNG locus direct cell type-specific expression. J Immunol. 2010;185(3):1492-501.
16. Eivazova ER, Aune TM. Dynamic alterations in the conformation of the Ifng gene region during T helper cell differentiation. Proc Natl Acad Sci. 2004;101(1):251-6.
17. Aune TM, Collins PL, Collier SP, Henderson MA, Chang S. Epigenetic activation and silencing of the gene that encodes IFN-γ. Front Immunol. 2013;4:112.
18. Chang S, Aune TM. Histone hyperacetylated domains across the Ifng gene region in natural killer cells and T cells. Proc Natl Acad Sci U S A. 2005;102:17095-100.
19. Schoenborn JR, Dorschner MO, Sekimata M, Santer DM, Shnyreva M, Fitzpatrick DR, et al. Comprehensive epigenetic profi ling identifies multiple distal regulatory elements directing transcription of the gene encoding interferon-gamma. Nat Immunol. 2007;8:732-42.
20. Falek PR, Ben-Sasson SZ, Ariel M. Correlation between DNA methylation and murine IFN-γ and IL-4 expression. Cytokine. 2000;12(3):198-206.
21. Phillips JE, Corces VG. CTCF: master weaver of the genome. Cell. 2009;137:1194-211.
22. Morinobu A, Gadina M, Strober W, Visconti R, Fornace A, Montagna C, O’Shea JJ, et al. STAT4 serine phosphorylation is critical for IL-12-induced IFN-γ production but not for cell proliferation. Proc Natl Acad Sci. 2002;99(19):12281-6.
23. Willingham AT, Orth AP, Batalov S, Peters EC, Wen BG, AzaBlanc P, et al. A strategy for probing the function of noncoding RNAs fi nds a repressor of NFAT. Science. 2005;309:1570-3.
24. Vigneau S, Rohrlich PS, Brahic M, Bureau JF. Tmevpg1, a candidate gene for the control of Theiler’s virus persistence, could be implicated in the regulation of gamma interferon. J Virol. 2003;77:5632-8.
25. Muljo SA, Ansel KM, Kanellopoulou C, Livingston DM, Rao A, Rajewsky K. Aberrant T cell differentiation in the absence of Dicer. J Exp Med. 2005;202:261-9.
26. Dorhoi A, Iannaccone M, Farinacci M, Faé KC, Schreiber J, Moura-Alves P, Kaufmann SHE. MicroRNA-223 controls susceptibility to tuberculosis by regulating lung neutrophil recruitment. The Journal of Clinical Investigation. 2013;123(11):4836-48. http://doi.org/10.1172/JCI67604.
27. Dai R, Phillips RA, Zhang Y, Khan D, Crasta O, Ahmed SA. Suppression of LPS-induced interferon-γ and nitric oxide in splenic lymphocytes by select estrogen-regulated microRNAs: a novel mechanism of immune modulation. Blood. 2008;112(12):4591-7.
28. Park H, Huang X, Lu C, Cairo MS, Zhou X. MicroRNA-146a and microRNA-146b regulate human dendritic cell apoptosis and cytokine production by targeting TRAF6 and IRAK1 proteins. J Biol Chem. 2015;290(5):2831-41.
29. Ma F, Xu S, Liu X, Zhang Q, Xu X, Liu M, Cao X, et al. The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-[gamma]. Nat Immunol. 2011;12(9):861-9.
30. Steiner DF, Thomas MF, Hu JK, Yang Z, Babiarz JE, Allen CD, Ansel KM, et al. MicroRNA-29 regulates T-box transcription factors and interferon-γ production in helper T cells. Immunity. 2011;35(2):169-81.
31. Trotta R, Chen L, Ciarlariello D, Josyula S, Mao C, Costinean S, Caligiuri MA, et al. miR-155 regulates IFN-γ production in natural killer cells. Blood. 2012;119(15):3478-85.
32. Manning BD, Cantley LC. AKT/PKB signaling: navigating downstream. Cell. 2007;129(7):1261-74.
33. Kasahara Tadashi, Hooks JJ, Dougherty SF, Oppenheim JJ. Interleukin 2-mediated immune interferon (IFN-gamma) production by human T cells and T cell subsets. J Immunol. 1983;130(4):1784-9.
34. Hibbert L, Pflanz S, de Waal Malefyt R, Kastelein RA. IL-27 and IFN-α signal via Stat1 and Stat3 and induce T-Bet and IL-12R β 2 in naive T cells. J Interf Cytokine Res. 2003;23(9):513-22.
35. Calarota SA, Otero M, Hermanstayne K, Lewis M, Rosati M, Felber BK, Weiner DB, et al. Use of interleukin 15 to enhance interferon-γ production by antigen-specific stimulated lymphocytes from rhesus macaques. J Immunol Methods. 2003;279(1):55-67.
36. Biet F, Locht C, Kremer L. Immunoregulatory functions of interleukin 18 and its role in defense against bacterial pathogens. J Mol Med. 2002;80(3):147-62.
37. Bird JJ, Brown DR, Mullen AC, Moskowitz NH, Mahowald MA, Sider JR, Reiner SL, et al. Helper T cell differentiation is controlled by the cell cycle. Immunity. 1998;9(2):229-37.
38. Kandasamy K, Mohan SS, Raju R, Keerthikumar S, Kumar GSS, Venugopal AK, Gollapudi SK, et al. NetPath: a public resource of curated signal transduction pathways. Genome Biol. 2010;11(1):1-9.
39. Strebovsky J, Walker P, Lang R, Dalpke AH. Suppressor of cytokine signaling 1 (SOCS1) limits NFkB signaling by decreasing p65 stability within the cell nucleus. FASEB J. 2011;25(3):863-74.
40. Gonsky R, Deem RL, Bream J, Young HA, Targan SR. Enhancer role of STAT5 in CD2 activation of IFN-γ gene expression. J Immunol. 2004;173(10):6241-7.
41. Presky DH, Yang H, Minetti LJ, Chua AO, Nabavi N, Wu CY, Gately MK, Gubler AU. functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunits. Proc Natl Acad Sci U S A. 1996;93:14002-7.
42. Park WR, Nakahira M, Sugimoto N, Bian Y, Yashiro-Ohtani Y, Zhou XY, Fujiwara H, et al. A mechanism underlying STAT4‐mediated up‐regulation of IFN‐y induction in TCR‐triggered T cells. Int Immunol. 2004;16(2):295-302.
43. Ouyang W, Jacobson NG, Bhattacharya D, Gorham JD, Fenoglio D, Sha WC, Murphy KM, et al. The Ets transcription factor ERM is Th1-specific and induced by IL-12 through a Stat4-dependent pathway. Proc Natl Acad Sci U S A. 1999;96(7):3888-93.
44. Afkarian M, Sedy JR, Yang J, Jacobson NG, Cereb N, Yang SY, Murphy KM, et al. T-bet is a STAT1-induced regulator of IL-12R expression in naive CD4+ T cells. Nat Immunol. 2002;3(6):549-57.
45. Hodge DL, Martinez A, Julias JG, Taylor Lynn S, Young HA. Regulation of nuclear gamma interferon gene expression by interleukin 12 (IL-12) and IL-2 represents a novel form of post transcriptional control. Mol Cell Biol. 2002;22(6):1742-53.
46. Cook KD, Miller J. TCR-dependent translational control of GATA-3 enhances Th2 differentiation. J Immunol. 2010;185(6):3209-16.
47. Gotthardt D, Putz EM, Straka E, Kudweis P, Biaggio M, Poli V, Sexl V, et al. Loss of STAT3 in murine NK cells enhances NK cell-dependent tumor surveillance. Blood. 2014;124(15):2370-9.
48. Pensa S, Regis G, Boselli D, Novelli F, Poli V. STAT1 and STAT3 in tumorigenesis: two sides of the same coin? 2000.
49. Hoshino K, Tsutsui H, Kawai T, Takeda K, Nakanishi K, Takeda Y, Akira S. Cutting edge: generation of IL-18 receptor-deficient mice: evidence for IL-1 receptor-related protein as an essential IL-18 binding receptor. J Immunol. 1999;162(9):5041-4.
50. Kalina U, Kauschat D, Koyama N, Nuernberger H, Ballas K, Koschmieder S, Ottmann OG, et al. IL-18 activates STAT3 in the natural killer cell line 92, augments cytotoxic activity, and mediates IFN-γ production by the stress kinase p38 and by the extracellular regulated kinases p44erk-1 and p42erk-21. J Immunol. 2000;165(3):1307-13.
51. Zarling S, Berenzon D, Dalai S, Liepinsh D, Steers N, Krzych U. The survival of memory CD8 T cells that is mediated by IL-15 correlates with sustained protection against malaria. J Immunol. 2013;190(10):5128-41.
52. Kumar A, Takada Y, Boriek AM, Aggarwal BB. Nuclear factor-kB: its role in health and disease. J Mol Med. 2004;82(7):434-48.
53. Matikainen S, Paananen A, Miettinen M, Kurimoto M, Timonen T, Julkunen I, Sareneva T. IFN‐α and IL‐18 synergistically enhance IFN‐y production in human NK cells: differential regulation of Stat4 activation and IFN‐y gene expression by IFN‐α and IL‐12. Eur J Immunol. 2001;31(7):2236-45.
54. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, De Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med. 1991;174(5):1209-20.
55. Varma TK, Toliver-Kinsky TE, Lin CY, Koutrouvelis AP, Nichols JE, Sherwood ER. Cellular mechanisms that cause suppressed gamma interferon secretion in endotoxin-tolerant mice. Infect Immun. 2001;69(9):5249-63.
56. Egwuagu CE, Larkin J. Therapeutic targeting of STAT pathways in CNS autoimmune diseases. JAK-STAT. 2013;2(1), e24134.
57. Schoenborn JR, Wilson CB. Regulation of interferon‐y during innate and adaptive immune responses. Adv Immunol. 2007;96:41-101.
58. Eivazova ER, Markov SA, Pirozhkova I, Lipinski M, Vassetzky YS. Recruitment of RNA polymerase II in the Ifng gene promoter correlates with the nuclear matrix association in activated T helper cells. J Mol Biol. 2007;371(2):317-22.
59. Knox JJ, Cosma GL, Betts MR, McLane LM. Characterization of T-bet and eomes in peripheral human immune cells. Front Immunol. 2014;5:217.
60. Szabo SJ, Sullivan BM, Stemmann C, Satoskar AR, Sleckman BP, Glimcher LH. Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science (New York, NY). 2002;295(5553):338.
61. Yang Y, Ochando JC, Bromberg JS, Ding Y. Identification of a distant T-bet enhancer responsive to IL-12/Stat4 and IFNγ/Stat1 signals. Blood. 2007;110(7):2494-500.
62. Hamilton SE, Jameson SC. CD8+ T cell differentiation: choosing a path through T-bet. Immunity. 2007;27(2):180-2.
63. Gordon SM, Chaix J, Rupp LJ, Wu J, Madera S, Sun JC, Reiner SL, et al. The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation. Immunity. 2012;36(1):55-67.
64. Samten B, Townsend JC, Weis SE, Bhoumik A, Klucar P, Shams H, Barnes PF. CREB, ATF, and AP-1 transcription factors regulate IFN-γ secretion by human T cells in response to mycobacterial antigen. J Immunol. 2008;181(3):2056-64.
65. Maciaân F, Lâopez-Rodrâiguez C, Rao A. Partners in transcription: NFAT and AP-1. Oncogene. 2001;20:2476-89.
66. Hatton RD, Harrington LE, Luther RJ, Wakefield T, Janowski KM, Oliver JR, Weaver CT, et al. A distal conserved sequence element controls Ifng gene expression by T cells and NK cells. Immunity. 2006;25(5):717-29.
67. Sica A, Dorman L, Viggiano V, Cippitelli M, Ghosh P, Rice N, Young HA. Interaction of NF-kB and NFAT with the interferon-γ promoter. J Biol Chem. 1997;272(48):30412-20.
68. Wang L, Zhu J, Shan S, Qin Y, Kong Y, Liu J, Xie Y, et al. Repression of interferon-γ expression in T cells by Prospero-related homeobox protein. Cell Res. 2008;18(9):911-20.
69. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature. 1998;391(6662):79-82.
70. Cunard R, Eto Y, Muljadi JT, Glass CK, Kelly CJ, Ricote M. Repression of IFN-gamma expression by peroxisome proliferator-activated receptor gamma. J Immunol. 2004;172:7530-6.
71. Waite KJ, Floyd ZE, Arbour-Reily P, Stephens JM. Interferon-γ-induced regulation of peroxisome proliferator-activated receptor γ and STATs in adipocytes. J Biol Chem. 2001;276(10):7062-8.
72. Dunn SE, Ousman SS, Sobel RA, Zuniga L, Baranzini SE, Youssef S, Steinman L, et al. Peroxisome proliferator-activated receptor (PPAR) α expression in T cells mediates gender differences in development of T cell-mediated autoimmunity. J Exp Med. 2007;204(2):321-30.
73. Lin JT, Martin SL, Xia L, Gorham JD. TGF-β1 uses distinct mechanisms to inhibit IFN-γ expression in CD4+ T cells at priming and at recall: differential involvement of Stat4 and T-bet. J Immunol. 2005;174(10):5950-8.
74. Yu J, Wei M, Becknell B, Trotta R, Liu S, Boyd Z, Mao H, et al. Pro-and antiinflammatory cytokine signaling: reciprocal antagonism regulates interferon-gamma production by human natural killer cells. Immunity. 2006;24(5):575-90.
75. Savignac M, Pintado B, Gutierrez-Adan A, Palczewska M, Mellström B, Naranjo JR. Transcriptional repressor DREAM regulates T‐lymphocyte proliferation and cytokine gene expression. EMBO J. 2005;24(20):3555-64.
76. Yagi R, Zhu J, Paul WE. An updated view on transcription factor GATA3-mediated regulation of Th1 and Th2 cell differentiation. Int Immunol. 2011;23(7):415-20.
77. Kim K, Kim N, Lee GR. Transcription factors Oct-1 and GATA-3 cooperatively regulate Th2 cytokine gene expression via the RHS5 within the Th2 locus control region. PLoS ONE. 2016;11(2), e0148576.
78. Kaminuma O, Kitamura F, Kitamura N, Miyagishi M, Taira K, Yamamoto K, Miyatake S, et al. GATA-3 suppresses IFN-γ promoter activity independently of binding to cis-regulatory elements. FEBS Lett. 2004;570(1):63-8.
79. Djuretic IM, Levanon D, Negreanu V, Groner Y, Rao A, Ansel KM. Transcription factors T-bet and Runx3 cooperate to activate Ifng and silence Il4 in T helper type 1 cells. Nat Immunol. 2007;8(2):145-53.
80. Penix L, Weaver WM, Pang Y, Young HA, Wilson CB. Two essential regulatory elements in the human interferon gamma promoter confer activation specifi c expression in T cells. J Exp Med. 1993;178(5):1483-96.
81. Ye J, Cippitelli M, Dorman L, Ortaldo JR, Young HA. The nuclear factor YY1 suppresses the human gamma interferon promoter through two mechanisms: inhibition of AP1 binding and activation of a silencer element. Mol Cell Biol. 1996;16(9):4744-53.
82. Hodge DL, Berthet C, Coppola V, Kastenmüller W, Buschman MD, Schaughency PM, Ortaldo JR, et al. IFN-gamma AU-rich element removal promotes chronic IFN-gamma expression and autoimmunity in mice. J Autoimmun. 2014;53:33-45.
83. Ben-Asouli Y, Banai Y, Pel-Or Y, Shir A, Kaempfer R. Human interferon-gamma mRNA autoregulates its translation through a pseudoknot that activates the interferon-inducible protein kinase PKR. Cell. 2002;108(2):221-32.
84. Williams BR. PKR; a sentinel kinase for cellular stress. Oncogene. 1999;18(45):6112-20.
85. Sareneva T, Cantell K, Pyhälä L, Pirhonen J, Julkunen I. Effect of carbohydrates on the pharmacokinetics of human interferon-γ. J Interf Res. 1993;13(4):267-9.
86. Pesu M, Muul L, Kanno Y, O’Shea JJ. Proprotein convertase furin is preferentially expressed in T helper 1 cells and regulates interferon gamma. Blood. 2006;108:983-5.